Tumor cells with MYC overexpression exhibit cell cycle dysregulation, which may make their proliferation particularly sensitive to the inhibition of an important regulator of cell cycle progression - cyclin-dependent kinase (CDK) (Icard et al., 2019; Baluapuri et al., 2020). The gene discussed is MYC; the disease is neoplasm.